Fellowship · Rochester, NY
Sponsored by University of Rochester Medicine
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2022 · 240 citations · Ruth M. O'Regan
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 260 citations · Ruth M. O'Regan
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 183 citations · Ruth M. O'Regan
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 138 citations · Barbara Asselin
A National Mental Health Profile of Parents of Children With Medical Complexity.
Pediatrics · 2021 · 83 citations · Nathaniel Bayer
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.
Leukemia · 2024 · 64 citations · Barbara Asselin
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 67 citations · Barbara Asselin
Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel.
Science translational medicine · 2021 · 108 citations · Ruth M. O'Regan